Dopamine treatment and cognitive functioning in individuals with parkinson's disease: The "cognitive flexibility" hypothesis seems to work

Behavioural Neurology

Volumn 2014, Issue , 2014, Pages

  Costa, Alberto ^a   Peppe, Antonella ^a   Mazzù, Ilenia ^a   Longarzo, Mariachiara ^a   Caltagirone, Carlo ^a,b   Carlesimo, Giovanni A ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ANTIPARKINSON AGENT; LEVODOPA;

AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CORPUS STRIATUM; FEMALE; HUMAN; MALE; NEUROMODULATION; ON OFF PHENOMENON; PARKINSON DISEASE; STROOP TEST; TASK PERFORMANCE; TREATMENT OUTCOME; DRUG EFFECTS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; REACTION TIME;

AGED; ANTIPARKINSON AGENTS; COGNITION; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REACTION TIME; TREATMENT OUTCOME;

EID: 84898634373     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.1155/2014/260896     Document Type: Article

References (60)

1. R. Cools and M. D'Esposito, "Inverted-U-shaped dopamine actions on human working memory and cognitive control," Biological Psychiatry, vol. 69, no. 12, pp. e113-e125, 2011.
2. R. Cools,M. Sheridan,E. Jacobs, andM.D'Esposito, "Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory," The Journal of Neuroscience, vol. 27, no. 20, pp. 5506-5514, 2007.
3. D. Y. Kimberg, M. D'Esposito, and M. J. Farah, "Effects of bromocriptine on human subjects depend on workingmemory capacity," NeuroReport, vol. 8, no. 16, pp. 3581-3585, 1997.
4. M. A. Mehta, R. Swainson, A. D. Ogilvie, B. Sahakian, and T. W. Robbins, "Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers," Psychopharmacology, vol. 159, no. 1, pp. 10-20, 2001.
5. M. A. Mehta, F. F. Manes, G. Magnolfi, B. J. Sahakian, and T. W. Robbins, "Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers," Psychopharmacology, vol. 176, no. 3-4, pp. 331-342, 2004.
6. R. Cools, "Dopaminergic control of the striatum for high-level cognition," Current Opinion in Neurobiology, vol. 21, no. 3, pp. 1-6, 2011.
7. A.M. Owen, "Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry," Neuroscientist, vol. 10, no. 6, pp. 525-537, 2004.
8. R. Cools, "Dopaminergic modulation of cognitive functionimplications for L-DOPA treatment in Parkinson's disease," Neuroscience and Biobehavioral Reviews, vol. 30, no. 1, pp. 1-23, 2006.
9. S. J. Fallon, C. H. Williams-Gray, R. A. Barker, A. M. Owen, and A. Hampshire, "Prefrontal dopamine levels determine the balance between cognitive stability and flexibility," Cerebral Cortex, vol. 23, no. 2, pp. 361-369, 2013.
10. M. J. Frank and J. A. Fossella, "Neurogenetics and pharmacology of learning, motivation, and cognition," Neuropsychopharmacology, vol. 36, no. 1, pp. 133-152, 2011.
11. H. S. Crofts, J.W. Dalley, P. Collins et al., "Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set," Cerebral Cortex, vol. 11, no. 11, pp. 1015-1026, 2001.
12. A. C. Roberts, M. A. de Salvia, L. S. Wilkinson et al., "6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin card sort test: possible interactions with subcortical dopamine," The Journal of Neuroscience, vol. 14, no. 5 I, pp. 2531-2544, 1994.
13. A. M. Gotham, R. G. Brown, and C. D. Marsden, "'Frontal' cognitive function in patients with Parkinson's disease "on" and "off " levodopa," Brain, vol. 111, part 2, pp. 299-321, 1988.
14. Y. Agid,M. Ruberg, F. Javoy-Agid et al., "Are dopaminergic neurons selectively vulnerable to Parkinson's disease?" Advances in Neurology, vol. 60, pp. 148-164, 1993.
15. E. H. Yeterian and D. N. Pandya, "Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys," Journal of Comparative Neurology, vol. 312, no. 1, pp. 43-67, 1991.
16. A. Costa, A. Peppe, G. Dell'Agnello, C. Caltagirone, and G. A. Carlesimo, "Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory," Neuropsychologia, vol. 47, no. 5, pp. 1374-1381, 2009.
17. A. Costa, A. Peppe, G. Dell'Agnello et al., "Dopaminergic modulation of visual-spatial working memory in Parkinson's disease," Dementia and Geriatric Cognitive Disorders, vol. 15,no. 2, pp. 55-66, 2003.
18. A. Costa, A. Peppe, L. Brusa, C. Caltagirone, I. Gatto, and G. A. Carlesimo, "Levodopa improves time-based prospective memory in Parkinson's disease," Journal of the International Neuropsychological Society, vol. 14, no. 4, pp. 601-610, 2008.
19. D. Y. Kimberg and M. D'Esposito, "Cognitive effects of the dopamine receptor agonist pergolide," Neuropsychologia, vol. 41, no. 8, pp. 1020-1027, 2003.
20. J. D. Cohen, T. S. Braver, and J.W. Brown, "Computational perspectives on dopamine function in prefrontal cortex," Current Opinion in Neurobiology, vol. 12, no. 2, pp. 223-229, 2002.
21. M. J. Frank, "Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism," Journal of Cognitive Neuroscience, vol. 17, no. 1, pp. 51-72, 2005.
22. M. J. Frank, B. Loughry, and R. C. O'Reilly, "Interactions between frontal cortex and basal ganglia in working memory: a computational model," Cognitive, Affective and Behavioral Neuroscience, vol. 1, no. 2, pp. 137-160, 2001.
23. M. Camps, P. H. Kelly, and J. M. Palacios, "Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species," Journal of Neural Transmission, vol. 80, no. 2, pp. 105-127, 1990.
24. H. S. Crofts, J. W. Dalley, P. Collins et al., "Parkinson's disease: mechanism and models," Neuron, vol. 39, pp. 889-909, 2003.
25. P. Collins, L. S. Wilkinson, B. J. Everitt, T. W. Robbins, and A. C. Roberts, "The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function," Behavioral Neuroscience, vol. 114, no. 1, pp. 3-17, 2000.
26. P. A. MacDonald and O. Monchi, "Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function," Parkinson's Disease, vol. 2011, Article ID 572743, 6 pages, 2011.
27. A. A. Kehagia, R. A. Barker, and T. W. Robbins, "Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease," The Lancet Neurology, vol. 9, no. 12, pp. 1200-1213, 2010.
28. M. Kliegel, M. Altgassen, A. Hering, and N. S. Rose, "A processmodel based approach to prospective memory impairment in Parkinson's disease," Neuropsychologia, vol. 49, no. 8, pp. 2166-2177, 2011.
29. R. Cools, R. A. Barker, B. J. Sahakian, and T. W. Robbins, "L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease," Neuropsychologia, vol. 41, no. 11, pp. 1431-1441, 2003.
30. R. Cools, A. Miyakawa, M. Sheridan, and M. D'Esposito, "Enhanced frontal function in Parkinson's disease," Brain, vol. 133, part 1, pp. 225-233, 2010.
31. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, "Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases," Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181-184, 1992.
32. M. F. Folstein, S. E. Folstein, and P. R. McHugh, "'Mini mental state'. A practical method for grading the cognitive state of patients for the clinician," Journal of Psychiatric Research, vol. 12, no. 3, pp. 189-198, 1975.
33. G.Measso, F. Cavarzeran, G. Zappala et al., "The MiniMental State examination: normative study of a random sample of the Italian population," Developmental Neuropsychology, vol. 9, pp. 77-85, 1991.
34. S. Fahn and R. L. Elton, "Unified Parkinson's disease rating scale," in Recent Developments in Parkinson's Disease, S. Fahn, P. D. Marsden, D. B. Calne, and A. Lieberman, Eds., pp. 153-163, Macmillan Health Care Information, Florham Park, NJ, USA, 1987.
35. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, "Systematic review of levodopa dose equivalency reporting in Parkinson's disease," Movement Disorders, vol. 25, no. 15, pp. 2649-2653, 2010.
36. G. A. Carlesimo, C. Caltagirone, and G. Gainotti, "The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment," European Neurology, vol. 36, no. 6, pp. 378-384, 1996.
37. G. A. Carlesimo, I. Buccione, L. Fadda et al., "Standardizzazione di due test di memoria per uso clinico: breve racconto e figura di Rey," Nuova Rivista di Neurologia, vol. 12, pp. 1-13, 2002.
38. M. Monaco, A. Costa, C. Caltagirone, and G. A. Carlesimo, "Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population," Neurological Sciences, vol. 34, no. 5, pp. 749-754, 2013.
39. U. Nocentini, S. Di Vincenzo, M. Panella, P. Pasqualetti, and C. Caltagirone, "La valutazione delle funzioni esecutive nella pratica neuropsicologica, dal Modified Card Sorting Test al Modified Card Sorting Test-Roma Version. Dati di standardizzazione," Nuova Rivista di Neurologia, vol. 12, no. 1, pp. 13-24, 2002.
40. R. de Bleser, G. Denes, C. Luzzatti et al., "L'Aachener Aphasie test I: problemi e soluzioni per una versione italiana del test e per uno studio crosslinguistico dei disturbi afasici," Archivio di Psicologia, Neurologia e Psichiatria, vol. 47, pp. 209-236, 1986.
41. J.W. Langston, H.Widner, C. G. Goetz et al., "Core assessment program for intracerebral transplantations (CAPIT)," Movement Disorders, vol. 7, no. 1, pp. 2-13, 1992.
42. C. Golden, Stroop Color and Word Test. Manual, Stoelting, Chicago, Ill, USA, 1978.
43. M. B. Jurado and M. Rosselli, "The elusive nature of executive functions: a review of our current understanding," Neuropsychology Review, vol. 17, no. 3, pp. 213-233, 2007.
44. H. Spinnler and G. Tognoni, "Standardizzazione e taratura italiana di test neuropsicologici," The Italian Journal of Neurological Sciences, vol. 8, supplement, pp. 1-20, 1987.
45. J. J.Downes, H.M. Sharp, B.M. Costall, H. J. Sagar, andJ.Howe, "Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment," Brain, vol. 116, part 4, pp. 887-902, 1993.
46. J. D. Henry and J. R. Crawford, "Verbal fluency deficits in Parkinson's disease: ameta-Analysis," Journal of the International Neuropsychological Society, vol. 10, no. 4, pp. 608-622, 2004.
47. L. X. Blonder and J. T. Slevin, "Emotional dysfunction in Parkinson's disease," Behavioural Neurology, vol. 24, no. 3, pp. 201-217, 2011.
48. A. Costa, A. Peppe, G. A. Carlesimo, P. Pasqualetti, and C. Caltagirone, "Major and minor depression in Parkinson's disease: a neuropsychological investigation," European Journal of Neurology, vol. 13, no. 9, pp. 972-980, 2006.
49. G. Santangelo, C.Vitale, L. Trojano et al., "Relationship between depression and cognitive dysfunctions in Parkinsons disease without dementia," Journal ofNeurology, vol. 256, no.4,pp. 632-638, 2009.
50. C. D. Spielberg, Manual for the State-Trait Anxiety Inventory, Consulting Psychologists Press, Palo Alto, Calif, USA, 1983.
51. A. T. Beck and R. A. Steer, Beck Depression Inventory Manual, Psychological Corporation, San Antonio, Tex, USA, 1987.
52. M. Visser, A. F. G. Leentjens, J. Marinus, A. M. Stiggelbout, and J. J. van Hilten, "Reliability and validity of the Beck Depression Inventory in patients with Parkinson's disease," Movement Disorders, vol. 21, no. 5, pp. 668-672, 2006.
53. T. Egner and J. Hirsch, "Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information," Nature Neuroscience, vol. 8, no. 12, pp. 1784-1790, 2005.
54. A. Miyake, N. P. Friedman, M. J. Emerson, A. H. Witzki, A. Howerter, and T.D.Wager, "The unity and diversity of executive functions and their contributions to complex, "Frontal Lobe" tasks: a latent variable analysis," Cognitive Psychology, vol. 41, no. 1, pp. 49-100, 2000.
55. G. Koch, A. Costa, L. Brusa et al., "Impaired reproduction of second but not millisecond time intervals in Parkinson's disease," Neuropsychologia, vol. 46, no. 5, pp. 1305-1313, 2008.
56. S. J. G. Lewis, A. Slabosz, T. W. Robbins, R. A. Barker, and A. M. Owen, "Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease," Neuropsychologia, vol. 43, no. 6, pp. 823-832, 2005.
57. P. A. MacDonald, A. A. MacDonald, K. N. Seergobin et al., "The effect of dopamine therapy on ventral and dorsal striatummediated cognition in Parkinson's disease: support from functional MRI," Brain, vol. 134, part 5, pp. 1447-1463, 2011.
58. X.Cai, S.Kim, andD. Lee, "Heterogeneous coding of temporally discounted values in the dorsal and ventral striatum during intertemporal choice," Neuron, vol. 69, no. 1, pp. 170-182, 2011.
59. L. Ding and J. I. Gold, "Caudate encodesmultiple computations for perceptual decisions," The Journal of Neuroscience, vol. 30, no. 47, pp. 15747-15759, 2010.
60. J. D. Cohen, M. Botvinick, and C. S. Carter, "Anterior cingulate and prefrontal cortex: who's in control?" Nature Neuroscience, vol. 3, no. 5, pp. 421-423, 2000.